Ernest Pedapati

Zag ElSayed, Grace Westerkamp, Gavin Gammoh et al.

We introduce EEG Autoclean Vision Language AI (ICVision) a first-of-its-kind system that emulates expert-level EEG ICA component classification through AI-agent vision and natural language reasoning. Unlike conventional classifiers such as ICLabel, which rely on handcrafted features, ICVision directly interprets ICA dashboard visualizations topography, time series, power spectra, and ERP plots, using a multimodal large language model (GPT-4 Vision). This allows the AI to see and explain EEG components the way trained neurologists do, making it the first scientific implementation of AI-agent visual cognition in neurophysiology. ICVision classifies each component into one of six canonical categories (brain, eye, heart, muscle, channel noise, and other noise), returning both a confidence score and a human-like explanation. Evaluated on 3,168 ICA components from 124 EEG datasets, ICVision achieved k = 0.677 agreement with expert consensus, surpassing MNE ICLabel, while also preserving clinically relevant brain signals in ambiguous cases. Over 97% of its outputs were rated as interpretable and actionable by expert reviewers. As a core module of the open-source EEG Autoclean platform, ICVision signals a paradigm shift in scientific AI, where models do not just classify, but see, reason, and communicate. It opens the door to globally scalable, explainable, and reproducible EEG workflows, marking the emergence of AI agents capable of expert-level visual decision-making in brain science and beyond.

Zag ElSayed, Grace Westerkamp, Jack Yanchen Liu et al.

Neurodevelopmental disorders such as Fragile X Syndrome (FXS) and Autism Spectrum Disorder (ASD) are characterized by disrupted cortical oscillatory activity, particularly in the alpha and gamma frequency bands. These abnormalities are linked to deficits in attention, sensory processing, and cognitive function. In this work, we present an adaptive machine learning-based brain-computer interface (BCI) system designed to modulate neural oscillations through frequency-specific auditory stimulation to enhance cognitive readiness in individuals with FXS. EEG data were recorded from 38 participants using a 128-channel system under a stimulation paradigm consisting of a 30-second baseline (no stimulus) followed by 60-second auditory entrainment episodes at 7Hz, 9Hz, 11Hz, and 13Hz. A comprehensive analysis of power spectral features (Alpha, Gamma, Delta, Theta, Beta) and cross-frequency coupling metrics (Alpha-Gamma, Alpha-Beta, etc.) was conducted. The results identified Peak Alpha Power, Peak Gamma Power, and Alpha Power per second per channel as the most discriminative biomarkers. The 13Hz stimulation condition consistently elicited a significant increase in Alpha activity and suppression of Gamma activity, aligning with our optimization objective. A supervised machine learning framework was developed to predict EEG responses and dynamically adjust stimulation parameters, enabling real-time, subject-specific adaptation. This work establishes a novel EEG-driven optimization framework for cognitive neuromodulation, providing a foundational model for next-generation AI-integrated BCI systems aimed at personalized neurorehabilitation in FXS and related disorders.

Zag ElSayed, Craig Erickson, Ernest Pedapati

Healthcare AI systems have historically faced challenges in merging contextual reasoning, long-term state management, and human-verifiable workflows into a cohesive framework. This paper introduces a completely innovative architecture and concept: combining the Model Context Protocol (MCP) with a specific clinical application, known as MCP-AI. This integration allows intelligent agents to reason over extended periods, collaborate securely, and adhere to authentic clinical logic, representing a significant shift away from traditional Clinical Decision Support Systems (CDSS) and prompt-based Large Language Models (LLMs). As healthcare systems become more complex, the need for autonomous, context-aware clinical reasoning frameworks has become urgent. We present MCP-AI, a novel architecture for explainable medical decision-making built upon the Model Context Protocol (MCP) a modular, executable specification for orchestrating generative and descriptive AI agents in real-time workflows. Each MCP file captures clinical objectives, patient context, reasoning state, and task logic, forming a reusable and auditable memory object. Unlike conventional CDSS or stateless prompt-based AI systems, MCP-AI supports adaptive, longitudinal, and collaborative reasoning across care settings. MCP-AI is validated through two use cases: (1) diagnostic modeling of Fragile X Syndrome with comorbid depression, and (2) remote coordination for Type 2 Diabetes and hypertension. In either scenario, the protocol facilitates physician-in-the-loop validation, streamlines clinical processes, and guarantees secure transitions of AI responsibilities between healthcare providers. The system connects with HL7/FHIR interfaces and adheres to regulatory standards, such as HIPAA and FDA SaMD guidelines. MCP-AI provides a scalable basis for interpretable, composable, and safety-oriented AI within upcoming clinical environments.